Target intelligence / Profile preview

Human metapneumovirus attachment glycoprotein (HMPV G)

Target
HMPV G
Molecular classification
Viral surface protein, Type II transmembrane glycoprotein, Attachment protein
01

Overview

The Human metapneumovirus (HMPV) attachment glycoprotein, or G protein, is a type II transmembrane surface protein essential for the initiation of viral infection. It facilitates the attachment of the virus to host cell receptors, primarily through interactions with glycosaminoglycans such as heparan sulfate on the surface of respiratory epithelial cells (UniProt P0C2Z6). The G protein is heavily glycosylated with both N-linked and O-linked sugars, which helps the virus evade host immune detection by masking antigenic sites and modulating the innate immune response, including the inhibition of type I interferon signaling (Bao et al., 2008, Journal of Virology). Structurally, it consists of an N-terminal cytoplasmic tail, a transmembrane domain, and a large, highly variable C-terminal extracellular domain. This high degree of sequence variability between HMPV lineages A and B makes the G protein a challenging target for universal vaccine development compared to the more conserved fusion (F) protein (Thiempanawong et al., 2021, Viruses). Nevertheless, it remains a critical target for understanding viral pathogenesis and is a key component in the study of HMPV-induced respiratory diseases like bronchiolitis and pneumonia, particularly in pediatric, elderly, and immunocompromised populations.

Other names
G proteinAttachment protein GHMPV G proteinMajor surface glycoprotein G
02

Mechanism of action

Neutralization of viral infectivity by blocking the attachment of the virus to host cell surface receptors, such as glycosaminoglycans, thereby preventing viral entry and subsequent replication.

03

Biological functions

Viral attachmentHost cell entryImmune evasionInhibition of interferon signalingModulation of host immune response
04

Disease associations

InfectionBronchiolitisPneumoniaUpper respiratory tract infectionLower respiratory tract infection
05

Safety considerations

High sequence variability between lineages A and BAntigenic drift leading to immune escapePotential for low cross-reactivity between different viral strainsChallenges in achieving broad-spectrum protection
06

Interacting drugs

Investigational mRNA vaccines (e.g., mRNA-1653)

1 more in the full profile.

07

Biomarkers

HMPV viral load (RNA)Anti-G protein antibody titersG-specific T-cell response

Beyond the preview

Go deeper on Human metapneumovirus attachment glycoprotein (HMPV G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human metapneumovirus attachment glycoprotein (HMPV G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call